ClinicalTrials.Veeva

Menu

Brazilian Registry of Menopausal Health (EMBRACE)

S

Science Valley Research Institute

Status

Enrolling

Conditions

Menopause

Study type

Observational

Funder types

Other

Identifiers

NCT07005648
EMBRACE

Details and patient eligibility

About

The Brazilian Registry of Menopausal Health is a national study aimed to better understand the health and quality of life of participants aged 35 to 65 who are in the menopausal transition or postmenopausal phase, including cisgender women and transgender men.

The study's hypothesis is that significant regional and socioeconomic disparities influence individuals' health, knowledge, and perception of menopause.

Full description

The Brazilian Registry of Menopausal Health, called EMBRACE STUDY (Endrocrine Mapping in the Broad Range Of Aging and Climateric Experiences), is an observational, cross-sectional, population-based study conducted with the objective of characterizing the epidemiological aspects of the Brazilian population during the menopausal transition and postmenopause, as well as the factors associated with clinical profiles and symptomatology, socioeconomic conditions, social inequalities, access to healthcare services, quality of life, and knowledge about menopause.

The study will include cisgender women and transgender men who have not undergone surgical or hormonal gender reassignment of secondary sexual characteristics, aged between 35 and 65 years, who seek outpatient care in public or private healthcare services. Data about transgender men will be collected for exploratory purposes.

A total of 1,592 participants will be enrolled, with 617, 509, and 466 participants in the respective age groups of 35-44, 45-54, and 55-65 years, proportionally stratified across the 27 state capitals of Brazil. These age groups will be used solely for the purpose of sample stratification. Data will be collected during a routine outpatient visit, without requiring additional study visits. Information will be obtained through a single interview, routine test results, and self-reported questionnaires.

A subgroup of 150 participants will undergo non-invasive instrumental and biometric assessments and high-resolution digital photography as an optional assessment of skin and hair physiology. Selected study centers will be chosen based on infrastructure and logistical feasibility, considering regional differences in temperature and humidity that may influence skin and hair characteristics.

Enrollment

1,592 estimated patients

Sex

All

Ages

35 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Women aged between 35 and 65 years attending medical consultation at public and private outpatient health services;
  2. Ability to confirm voluntary participation and sign the Informed Consent Form

Exclusion criteria

  1. Inability to respond to the interview for any reason
  2. Suspected or confirmed pregnancy
  3. Lactation
  4. Uncontrolled diabetes
  5. Uncontrolled arterial hypertension
  6. Uncontrolled thyroid disorders
  7. Grade 3 obesity, defined by a BMI equal to or greater than 40.0 kg/m²
  8. Diagnosis of psychiatric disorders that may compromise participation in the interview
  9. Previous hysterectomy
  10. Previous oophorectomy
  11. Current use of illicit drugs

Trial design

1,592 participants in 3 patient groups

617 participants = 35 to 44 years old
509 participants = 45 to 54 years old
466 participants = 55 to 65 years old

Trial contacts and locations

1

Loading...

Central trial contact

Leandro Agati; Eduardo Ramacciotti, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems